Theradigm-Her-2

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameTheradigm-Her-2

Drug Alias NameN/A

ClassificationVaccines

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEpimmune Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEpimmune Inc

Active IndicationsN/A

Inactive IndicationsOvarian NeoplasmsBreast Neoplasms

ATC CodeN/A